1 |
Bupropion
| 2件: Bupropion Bupropion; Bupropion Hydrochloride | 3件: D00817
D00817
,
D07591
,
D07938
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
2 |
Caffeine
| 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 2 2, 6, 13, 21, 46, 78, 96, 97, 265 |
3 |
Cariprazine
| 1件: Reagila Reagila | 1件: D09997
D09997
| 3件: DRD2 DRD2, HTR1A, HTR2A 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 21 21 |
4 |
Creatine
| 1件: Creatine Creatine | - | - | - | 16件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
5 |
Cysteamine
| 8件: 2-aminoethanethiol 2-aminoethanethiol; Beta-Mercaptoethylamine; CYSTADROPS; CYSTAGON; Cysteamine; Mercaptamina; Mercaptamine; PROCYSBI | 2件: D03634
D03634
,
D03635
| - | - | 4件: 8 8, 19, 21, 299 |
6 |
Dexmedetomidine
| 4件: Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
7 |
Dextromethorphan
| 4件: Dextromethorphan Dextromethorphan; DEXTROMETHORPHAN HYDROBROMIDE; Dextrometorfano; Nuedexta | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
8 |
Elamipretide
| 1件: Elamipretide Elamipretide | 1件: D10925
D10925
| - | - | 2件: 21 21, 324 |
9 |
Flurbiprofen
| 1件: Flurbiprofen Flurbiprofen | 3件: D00330
D00330
,
D01475
,
D02290
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
10 |
Haemagglutinin-strain B
| 2件: Fluzone Fluzone; Influvac | - | - | - | 4件: 21 21, 46, 49, 50 |
11 |
Influenza A virus A/Brisbane/59/2007 (H1N1) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
12 |
Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
13 |
Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
14 |
Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
15 |
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
16 |
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
17 |
Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
18 |
Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
19 |
Influenza B virus B/Massachusetts/2/2012 antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
20 |
Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
21 |
Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
22 |
Influenza B virus B/Texas/6/2011 antigen (formaldehyde inactivated)
| 1件: Fluzone Fluzone | - | - | - | 2件: 21 21, 49 |
23 |
Midazolam
| 2件: Midazolam Midazolam; Midazolam injection | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
24 |
Omeprazole
| 5件: Losec Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 16件: 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
25 |
Phenylbutyric acid
| 4件: 4-phenylbutyrate 4-phenylbutyrate; Pheburane; Phenylbutyrate; Sodium phenylbutyrate | - | - | - | 14件: 2 2, 3, 6, 8, 15, 21, 93, 94, 231, 244, 251, 297, 299, 338 |
26 |
Propofol
| 2件: PROPOFOL PROPOFOL; Propofol Injection | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 10件: 6 6, 21, 22, 34, 46, 70, 75, 84, 98, 296 |
27 |
Repaglinide
| 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 3件: 6 6, 21, 299 |
28 |
Sevoflurane
| 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
29 |
Sonlicromanol
| 1件: Sonlicromanol Sonlicromanol | - | - | - | 1件: 21 21 |
30 |
Tocotrienol
| 1件: Tocotrienol Tocotrienol | - | - | - | 3件: 21 21, 156, 299 |
31 |
Uridine triacetate
| 1件: Tri-O-acetyluridine Tri-O-acetyluridine | 1件: D09985
D09985
| - | - | 1件: 21 21 |
32 |
Vatiquinone
| 1件: VATIQUINONE VATIQUINONE | 1件: D10407
D10407
| - | - | 2件: 18 18, 21 |